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Presentation of
Process

Introduction
A very common type of
dilated cardiomyopathy is
ischemic cardiomyopathy.
Ischemic cardiomyopathy
is very important to review
due to its ability to affect a
patient’s health in a major
way. Coronary artery
disease is one of the top
killers in America; Ischemic
cardiomyopathy involves it
and a weakened heart
muscle. This weakened
heart muscle can cause an
array of problems for the
patient. Education of
diseases is important for
nurses so we can better
treat and educate our
patients. With working in
the cardiac catheterization
lab, seeing patients with
ischemic disease is very
common. Making patients
aware of the signs and
symptoms of coronary
disease is important so it
can be revascularized and
hopefully not develop into
ischemic cardiomyopathy.

•

•

The diagnosis of ischemic
cardiomyopathy involves a
thorough physical
examination, symptom
assessment,
echocardiography,
electrocardiography, stress
test, imaging studies, and
coronary catheterization.
Cardiovascular magnetic
resonance imaging allows
the assessment of
myocardial function,
perfusion, contractile
reserve and extent of
fibrosis in a single
comprehensive exam. This
is a great non-invasive tool
to use for diagnosis and
treatment options. It
detects myocardial
ischemia, viability of the
muscle, and the extent of
myocardial scarring, this
information helps
physician know to perform
revascularization, implant
a defibrillator, or which
medications to prescribe.

Implications for
Nursing Care
The main

Underlying Pathophysiology
According to Aksut MD, B. & Bott-Silverman MD, C., (2015)
•

implication of nursing care for
ischemic cardiomyopathy is

Ischemic cardiomyopathy is the most commonly identified specific cause of
dilated cardiomyopathy

•

Myocardial infarction causes localized myocyte necrosis, with resultant scar

patient education. The nurse

formation and loss of contractile function in the ventricular segment perfused

should educate the patient of the

by the culprit artery. In addition, the myocardium distal to the area of

following:

infarction develops increased wall stress, adverse remodeling, and chamber
dilation, so that a cardiomyopathic process occurs in adjacent nonischemic

•

Diet- restriction of sodium to
2,000-3,000 mg per day

•

•
•

•

Ischemic cardiomyopathy is generally ascribed to epicardial coronary
atherosclerosis, but it can also occur in any vasculitic process (eg, Takayasu’s

than 3 pounds in 2 days

arteritis), congenital abnormalities, embolic conditions (eg, atrial fibrillation,

Exercise- Non-competitive

endocarditis, thrombophilic states), cardiac allograft vasculopathy, and

aerobic exercises

microvascular ischemia.

Shortness of breath
Swelling of the legs and feet

•

Fatigue

•

Angina (Chest pain)

•

Weight gain, cough and

artery disease and heart attacks. The

congestion related to fluid

pump is increased by medications,

retention

revascularization, implantable

Palpitations due to abnormal

devices, or with transplant.

•

heart rhythms
•

Dizziness

Ischemic cardiomyopathy can occur as the direct result of myocardial
infarction or can result from repetitive ischemic results in those with poorly

Take prescribed medications

Treatment

controlled angina
•

.Decreased blood flow to the cardiac muscle makes it weak or even die, which
decreases its functionality as a pump.

1.

digoxin, diuretics, aldosterone

Due to the lack of blood flow to the cardiac muscle from coronary artery
disease the muscle becomes weak and dilated. The pump function is

inhibitors, and nitrates.
2.

Without an adequate pump function, the fluid is not pushed out which then

3.

or Implantable Cardioverter

shortness of breath and edema.
The ischemia causes the chest pain or angina; revascularization can be
performed to help reduce the angina.
•
•

Defibrillators
4.

due to fatal arrhythmias from the weak heart muscle.

RevascularizationAngioplasty, stents, or

The weak heart muscle can then cause arrhythmias which can be fatal.
Implantable Cardioverter Defibrillators are implanted to help prevent death

Implantable Devices- Cardiac
Resynchronization Therapy

causes fluid retention in the heart, lungs, and extremities. This is why the
•

Lifestyle changes of diet and
exercise

decreased which then causes the symptoms listed.
•

Medications such as betablockers, ACE Inhibitors,

Significance of Pathophysiology
•

Ischemic cardiomyopathy is when
the heart’s ability to pump blood is

•

Feelings of lightheaded or
•

Conclusion

•

areas.

Sudden weight gain- more

palpitations- call physician
•

Signs & Symptoms

coronary bypass graft surgery
5.

Heart transplant

decreased because the left ventricle is
enlarged, dilated, and weak. This is
due to lack of blood supply to the
heart muscle caused by coronary
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